Skip to content

Member

Georgia TRAMACERE

S&D · Italy

Group
S&D
Country
Italy
Roll-call participation
89.0 %ⓘ of 2 244 roll calls in office · chamber median 90.2 % · whole term, roll calls
With majority line
95.9 %ⓘ of 1 998 votes where the group had a line · S&D median 96.3 %
More facts (5)
National party
PD Partito Democratico
In office
Since 11 Feb 2026
Against clear line
59 of 1 950 votesⓘ
Committees
IMCO, ITRE (substitute), PETI, REGI (substitute)
Member id
275087
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

89.0 %

1 998 of 2 244 roll calls while in office

S&D median: 89.9 % (−0.8 pts)

Chamber median: 90.2 %

With majority line ⓘ

95.9 %

1 917 of 1 998 votes where their group had a line

S&D median: 96.3 % (−0.3 pts)

Against clear line ⓘ

3.0 %

59 of 1 950 votes where their group had a clear line

40 opposite (for ↔ against), 12 abstained against the line, 7 voted for or against when the line was to abstain

Abstention ⓘ

2.2 %

43 of 1 998 votes cast

Participation 89.0 % — S&D median 89.9 %, 138 members.ⓘ
Data as a table
Participation among the 138 members of the S&D with enough votes.
FigureParticipation
Georgia TRAMACERE89.0 %
S&D median89.9 %
Lowest in the group30.4 %
Highest in the group99.6 %
Members138
With majority line 95.9 % — S&D median 96.3 %, 138 members.ⓘ
Data as a table
With majority line among the 138 members of the S&D with enough votes.
FigureWith majority line
Georgia TRAMACERE95.9 %
S&D median96.3 %
Lowest in the group81.9 %
Highest in the group99.4 %
Members138
  • Whole term, 5 928 roll-call votes. The dots are the other members of S&D; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 231

Export

Every final roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecisionResultPositionMajority line
11 Mar 2026Recommendation on enhanced EU-Canada cooperation in the current geopolitical context, including the threats to Canada’s economic stability and sovereignty Adopted 482 for, 108 against, 42 abstainedPosition: For Majority line: For
11 Mar 2026Tackling barriers to the single market for defence Adopted 393 for, 169 against, 67 abstainedPosition: For Majority line: For
11 Mar 2026Flagship European defence projects of common interest Adopted 448 for, 122 against, 38 abstainedPosition: For Majority line: For
10 Mar 2026Harmonising certain aspects of insolvency law Passed 498 for, 90 against, 28 abstainedPosition: For Majority line: For
10 Mar 2026Establishing an EU talent pool Passed 414 for, 182 against, 21 abstainedPosition: For Majority line: For
10 Mar 2026Increased efficiency of the External Action Guarantee Passed 441 for, 105 against, 81 abstainedPosition: For Majority line: For
10 Mar 2026European Union regulatory fitness and subsidiarity and proportionality – report on Better Law-Making covering 2023 and 2024 Adopted 493 for, 92 against, 44 abstainedPosition: For Majority line: For
10 Mar 2026Housing crisis in the European Union with the aim of proposing solutions for decent, sustainable and affordable housing Adopted 367 for, 166 against, 84 abstainedPosition: For Majority line: For
10 Mar 2026Public access to documents - report 2022 - 2024 Adopted 602 for, 9 against, 8 abstainedPosition: For Majority line: For
10 Mar 2026Copyright and generative artificial intelligence – opportunities and challenges Adopted 460 for, 71 against, 88 abstainedPosition: For Majority line: For
10 Mar 2026Fisheries management approaches for safeguarding sensitive species, tackling invasive species and benefiting local economies Adopted 528 for, 21 against, 62 abstainedPosition: For Majority line: For
10 Mar 2026The upcoming European Research Area (ERA) Act Adopted 399 for, 78 against, 69 abstainedPosition: For Majority line: For
24 Feb 2026Four years of Russia’s war of aggression against Ukraine and European contributions to a just peace and sustained security for Ukraine Adopted 437 for, 82 against, 70 abstainedPosition: For Majority line: For
12 Feb 2026Cooperation among enforcement authorities regarding unfair trading practices in the agri-food supply chain Passed 555 for, 0 against, 26 abstainedPosition: No vote recorded Majority line: For
12 Feb 2026Post-election situation in Uganda and threats against opposition leader Bobi Wine Adopted 514 for, 3 against, 56 abstainedPosition: No vote recorded Majority line: For
12 Feb 2026Systemic oppression, inhumane conditions and arbitrary detentions by the regime in Iran Adopted 524 for, 3 against, 41 abstainedPosition: No vote recorded Majority line: For
12 Feb 2026Targeted expulsions of foreign journalists and foreign Christians in Türkiye under national security pretexts Adopted 502 for, 2 against, 59 abstainedPosition: No vote recorded Majority line: For
12 Feb 2026Developing a new EU anti-poverty strategy Adopted 385 for, 141 against, 53 abstainedPosition: No vote recorded Majority line: For
12 Feb 2026Addressing subcontracting chains and the role of intermediaries in order to protect workers’ rights Adopted 332 for, 209 against, 33 abstainedPosition: No vote recorded Majority line: For
12 Feb 2026Recommendation to the Council on EU priorities for the 70th session of the UN Commission on the Status of Women Adopted 340 for, 141 against, 68 abstainedPosition: No vote recorded Majority line: For
12 Feb 2026Situation in Northeast Syria, the violence against civilians and the need to maintain a sustainable ceasefire Adopted 363 for, 71 against, 81 abstainedPosition: No vote recorded Majority line: For
11 Feb 2026Regulation implementing enhanced cooperation on the establishment of the Ukraine Support Loan for 2026 and 2027 Passed 458 for, 140 against, 44 abstainedPosition: No vote recorded Majority line: For
11 Feb 2026Amending Regulation (EU) 2024/792 establishing the Ukraine Facility Passed 473 for, 140 against, 32 abstainedPosition: No vote recorded Majority line: For
11 Feb 2026Amending the multiannual financial framework for the years 2021 to 2027 Consent given 490 for, 130 against, 32 abstainedPosition: No vote recorded Majority line: For
11 Feb 2026Mobilisation of the European Globalisation Adjustment Fund: application EGF/2025/006 BE/Audi – Belgium Passed 593 for, 55 against, 9 abstainedPosition: No vote recorded Majority line: For
11 Feb 2026Genetically modified soybean DBN-09004-6 Objection passed 461 for, 169 against, 22 abstainedPosition: No vote recorded Majority line: For
11 Feb 2026Genetically modified maize T25 (ACS-ZMØØ3-2) Objection passed 462 for, 169 against, 22 abstainedPosition: No vote recorded Majority line: For
11 Feb 2026Genetically modified cotton T304-40 Objection passed 428 for, 156 against, 22 abstainedPosition: No vote recorded Majority line: For
11 Feb 2026Genetically modified cotton GHB614 × LLCotton25 Objection passed 463 for, 164 against, 21 abstainedPosition: No vote recorded Majority line: For
11 Feb 2026Interim report in view of the consent procedure on the Agreement establishing an association between the EU and the Principality of Andorra and the Republic of San Marino Interim report adopted 552 for, 24 against, 75 abstainedPosition: No vote recorded Majority line: For
11 Feb 2026EU strategic defence and security partnerships Adopted 440 for, 119 against, 85 abstainedPosition: No vote recorded Majority line: For

Show all 31 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 8 of 29 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table
Roll calls held at each sitting while in office and how many of them the member voted in.
SittingRoll callsVoted in
11 Feb 2026130
12 Feb 20261410
24 Feb 20264341
9 Mar 202610
10 Mar 2026197192
11 Mar 20266060
12 Mar 20263433
25 Mar 202633
26 Mar 20266969
27 Apr 202620
28 Apr 2026225220
29 Apr 2026296292
30 Apr 20266867
18 May 202640
19 May 202633
20 May 20269695
21 May 20269850
15 Jun 202620
16 Jun 20264039
17 Jun 2026127120
18 Jun 20267777
6 Jul 202620
7 Jul 20267272
8 Jul 2026144144
9 Jul 20266767
14 Sept 202610
15 Sept 2026155153
16 Sept 20268079
17 Sept 2026124122

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within S&D

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
Matteo RICCI S&DItaly99 % of 1 615 shared93 %
Giuseppe LUPO S&DItaly98 % of 1 697 shared93 %
Alessandra MORETTI S&DItaly98 % of 1 994 shared93 %
Sandro RUOTOLO S&DItaly98 % of 981 shared93 %
Nicola ZINGARETTI S&DItaly98 % of 1 724 shared93 %
Irene TINAGLI S&DItaly98 % of 1 956 shared93 %
Pierfrancesco MARAN S&DItaly98 % of 1 924 shared93 %
Stefano BONACCINI S&DItaly98 % of 1 931 shared93 %
Annalisa CORRADO S&DItaly98 % of 1 399 shared93 %
Raffaele TOPO S&DItaly97 % of 1 977 shared93 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Anna STÜRGKH RenewAustria90 % of 701 shared86 %
Irena JOVEVA RenewSlovenia90 % of 1 945 shared86 %
Yvan VEROUGSTRAETE RenewBelgium89 % of 1 820 shared86 %
Pascal CANFIN RenewFrance89 % of 1 785 shared86 %
Valérie HAYER RenewFrance89 % of 1 915 shared86 %
Anna-Maja HENRIKSSON RenewFinland89 % of 1 799 shared86 %
Marjan ŠAREC RenewSlovenia89 % of 1 838 shared86 %
Elisabetta GUALMINI changed group RenewItaly89 % of 1 709 shared86 %
Billy KELLEHER RenewIreland89 % of 1 986 shared86 %
Martin HOJSÍK RenewSlovakia89 % of 1 896 shared86 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on the Internal Market and Consumer ProtectionIMCO CommitteeMember24 Feb 2026now
Committee on Industry, Research and EnergyITRE CommitteeSubstitute23 Feb 2026now
Committee on PetitionsPETI CommitteeMember14 Sept 2026now
Committee on Regional DevelopmentREGI CommitteeSubstitute23 Feb 2026now
Delegation to the EU-Albania Stabilisation and Association Parliamentary CommitteeD-AL Joint parliamentary committeeMember9 Mar 2026now
Delegation to the Parliamentary Assembly of the Union for the MediterraneanDMED Parliamentary assemblyMember9 Mar 2026now

Show all 6 seats

Dossiers

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

4 contributions recorded; 4 minutes of speaking time.

Questions and motions, 15

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
7 Sept 2026Extraterritorial impact of the US designation of Autistici/Inventati as a terrorist entity P-10-2026-003526Priority written questionwith 28 co-authorsNot yet answered
1 Jul 2026PROPOSAL FOR A DECISION requesting the Authority for European Political Parties and European Political Foundations to verify whether Europe of Sovereign Nations Party complies with the conditions laid down in Article 3(1), points (d) and (e), of Regulation (EU, Euratom) 2025/2445 B-10-2026-0338Motion for a resolutionwith 246 co-authors—
24 Jun 2026State of play of the EU authorisation procedure for concessions from social security contributions for large companies in Southern Italy (Italian Law No 207/2024). E-10-2026-002591Written questionwith 4 co-authors25 Aug 2026
10 Jun 2026Potential conflict of interest in the appointment of the Special Envoy for Industrial AI P-10-2026-002401Priority written questionwith 37 co-authors13 Aug 2026
9 Jun 2026Protection of Italian citizen Nessy Guerra and her daughter, a minor, in Egypt E-10-2026-002377Written questionwith 23 co-authors7 Aug 2026
22 May 2026The theme parks sector E-10-2026-002124Written questionwith 3 co-authors28 Jul 2026
19 May 2026Employment conditions at the Italian National Institute of Astrophysics and protection of EU research funds E-10-2026-002070Written questionwith 6 co-authors3 Jul 2026
13 May 2026Another shooting attack by Libyan militias on the humanitarian vessel Sea-Watch 5 E-10-2026-002019Written questionwith 31 co-authors10 Aug 2026
11 May 2026The compatibility with EU law of the Italian 2026 Security Law’s video surveillance measure E-10-2026-001948Written questionwith 15 co-authors18 Sept 2026
21 Apr 2026Customs practices related to products imported from illegal Israeli settlements in the OPTs E-10-2026-001633Written questionwith 71 co-authors16 Jul 2026

Show all 15 questions and motions

Amendments tabled in committee, 11

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790005 CJ5317
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790932 CJ5327
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790933 CJ5311
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790934 CJ5314
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790935 CJ5324
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790936 CJ5317
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790937 CJ5311
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790938 CJ535
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790939 CJ5311
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790953 CJ538

Show all 11 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation Italy National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
25 September 2026

Cite as

EU Parl Watch Research (2026). “Georgia TRAMACERE”. Member record. memberId 275087. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/275087?page=5&speeches=all (retrieved 25 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/275087. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/275087?format=application%2Fld%2Bjson (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-275087,
  author = {{EU Parl Watch Research}},
  title = {{Georgia TRAMACERE}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/275087?page=5&speeches=all}},
  url = {https://news.eu-parl.st-solutions.dev/members/275087?page=5&speeches=all},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 275087. Official source: https://www.europarl.europa.eu/meps/en/275087. Data: EP Open Data: member record (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}